NEU neuren pharmaceuticals limited

Ann: Neuren and Acadia expand global partnership for trofinetide, page-40

  1. 518 Posts.
    lightbulb Created with Sketch. 1676
    Well - this makes alot of sense.

    In after-hours trading Acadia is now up to $31.7 a share. That's an increase in market cap of US$0.96b = AU$1.4 billion.

    Meanwhile, lame duck Neuren has risen just $1,59 a share - can't even reach the $15 it was just weeks ago. This $1.59 a share is a market cap increase of AU$200 million - less than one seventh Acadias increase!

    Neuren is easily worth AU$2 billion just on Acadia deal for Trof North America. So the market currently values Neuren's other opportunities plus this deal (including US$100 million up front cash) at -AU$300 million.

    The sooner Acadia do a share swap with Neuren and we get US listed shares (instead of the wet blanket ASX) the better!

    Am underwhelmed...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.